Clinical trial · Interventional
Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )
NCT06840847CI-TRIAL-00086431LHRHacompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The use of luteinizing hormone-releasing hormone agonists(LHRHa) to suppress ovarian function is a common strategy for treating premenopausal, hormone receptor-positive breast cancer. However, this approach can lead to more severe and prolonged menopausal symptoms, which can further impact intimate relationships and sexual function. Sexual coercion, encompassing both overt and subtle forms of pressure, is a significant global public health concern that threatens individual well-being.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sexual Coercion | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- LHRHa
- description
- In this study, included 40 patients on LHRHa. The instrument assessed partner sexual coercion in three domains: resource manipulation/sexual coercion, commitment manipulation, and threat of separation.
- interventionNames
- Behavioral: Sexual Coercion
- type
- ACTIVE_COMPARATOR
- label
- Tamoxifen (Nolvadex)
- description
- In this study included 39 patients on tamoxifen. The instrument assessed partner sexual coercion in three domains: resource manipulation/sexual coercion, commitment manipulation, and threat of separation.
- interventionNames
- Behavioral: Sexual Coercion
Primary outcomes (2)
- measure
- LHRHa
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * being over 18 years of age * willingness to participate in this study * having received treatment for breast cancer * having a history of breast cancer surgery * having an active relationship with a spouse or partner. Exclusion Criteria: * having any neuropsychiatric disorder * having any mental illness * having a history of gynecological surgery * currently receiving active chemotherapy or less than 3 months since completing chemotherapy * receiving treatment for metastatic disease * The use of selective serotonin reuptake inhibitors
References
Publications (0)
Data not yet available
No reference posted for this study.